Ozempic Side Effects: Complete Risk Guide & Fixes (2026)

Semaglutide side effects are real and worth understanding before you start — but for the large majority of users, they are manageable and temporary. Here is a complete guide to every documented side effect, how common each is, and exactly what to do about them.

Very Common Side Effects (affecting 10%+ of users)

Nausea — 44%

The most common and most discussed side effect. Caused by slowed gastric emptying and direct GLP-1 receptor activity in the brain stem. Typically worst at the starting dose and after each dose increase, improving over 2–4 weeks at each level. Management: eat smaller meals, avoid high-fat and spicy foods, eat slowly, avoid lying down after eating, take the injection at a consistent time (many find evening injections reduce daytime nausea). Anti-nausea medication (ondansetron) can be prescribed if severe.

Diarrhoea — 30%

Also dose-dependent and typically front-loaded to the first weeks of treatment. Can occur alongside or alternating with constipation. Management: stay hydrated, avoid high-fat foods that worsen transit, use probiotics, and consider loperamide for short-term relief. Usually resolves within 4–8 weeks.

Constipation — 24%

Caused by slowed colonic motility from GLP-1 receptor effects. Can persist longer than other GI side effects. Management: 2–3L water daily, dietary fibre from vegetables and psyllium, magnesium citrate 200–400mg daily, daily physical activity, and osmotic laxatives (MiraLAX) if needed. See our full constipation guide for details.

Vomiting — 24%

Related to nausea and gastric slowing. Most common in early weeks and after dose increases. Severe or prolonged vomiting can cause dehydration — oral rehydration fluids are important. If vomiting persists more than 48 hours or prevents adequate hydration, contact your prescriber.

Abdominal Pain — 20%

Often described as bloating, cramping, or fullness. Usually related to slowed gastric emptying and gas. Typically resolves within the first 1–2 months. Eating slowly and avoiding carbonated drinks can help.

Common Side Effects (affecting 1–10% of users)

Fatigue and low energy — particularly in the first weeks, linked to reduced caloric intake and metabolic adjustment. Prioritising adequate protein and not dropping calories too aggressively reduces this. Headache — often dehydration-related; increase fluid intake. Dizziness — can be from caloric restriction or dehydration; ensure adequate fluid and caloric intake. Hair loss (telogen effluvium) — affects approximately 3% of trial participants; caused by rapid weight loss, not the drug directly; largely preventable with adequate protein. Injection site reactions — redness, swelling, or itching at the injection site; typically mild and temporary; rotate injection sites.

Rare but Serious Side Effects

Pancreatitis: A small number of cases reported; large population studies do not show a meaningfully elevated risk compared to other diabetes/obesity treatments. If you experience severe persistent abdominal pain radiating to the back, stop the injection and seek medical care immediately.

Gallbladder problems: Gallstones and cholecystitis are associated with rapid weight loss regardless of mechanism — not unique to semaglutide. Slower, more gradual weight loss reduces this risk.

Hypoglycaemia: Low blood sugar risk is very low when semaglutide is used alone. Risk increases when combined with insulin or sulfonylureas. Diabetic patients on combination therapy should discuss monitoring with their prescriber.

Side Effects That Are NOT Common (Dispelling Myths)

Several side effects are widely discussed online but not well-supported by trial data: kidney failure is not a known semaglutide side effect (in fact kidney-protective effects are emerging); depression and suicidal ideation were investigated by the FDA in 2023 but no causal link was found in analysis of millions of users; and thyroid cancer has not been found at increased rates in human post-market surveillance despite the rodent C-cell concern.

Side Effect Management at a Glance

Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.